Financing ·
On August 4, 2026, Glucotrack, Inc. closed a $5.5 million financing comprising a $3.5 million follow-on investment in…
GCTKGlucotrack, Inc.
On August 4, 2026, Glucotrack, Inc. closed a $5.5 million financing comprising a $3.5 million follow-on investment in its existing bridge financing and a $2.0 million interim private placement. The $3.5 million Bridge Follow-On involves the issuance of senior secured convertible promissory notes with an aggregate principal amount of $3,500,000 and an aggregate face value of $4,487,179, reflecting a 22% original issue discount. These notes bear interest at 8% per annum, mature nine months from July 14, 2026, and are convertible subject to stockholder approval. The Interim PIPE raised $2.0 million through the sale of pre-funded warrants and common stock purchase warrants priced at $0.75 per unit. Glucotrack operates in the medical technology industry, focusing on the design, development, and commercialization of novel diabetes monitoring technologies.